The Treatment Effects of Empagliflozin on Renal Outcomes in Cardiorenal Syndrome Type 1

Clinical trial NCT06030843 · RECRUITING

Trial details

NCT number: NCT06030843
Sponsor: Chulalongkorn University
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Empagliflozin in Cardiorenal Syndrome Type 1

Start date: 2025-03-01
Primary completion: 2026-11-30
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.